Digital microfluidic platform for human plasma protein depletion

Ningsi Mei1, Brendon Seale, Alphonsus H C Ng

  • 1Department of Chemistry, Queen's University , 90 Bader Lane, Kingston, Ontario K7L 3N6, Canada.

Analytical Chemistry
|July 25, 2014
PubMed

Insights

This study introduces a rapid, automated method using digital microfluidics and magnetic beads to efficiently remove abundant proteins like human serum albumin (HSA) and immunoglobulins (IgGs) from serum samples. This technique enhances biomarker identification by improving signal-to-noise ratios in proteomic analysis.

Area of Science:

  • Biochemistry
  • Proteomics
  • Analytical Chemistry

Background:

  • Low-abundance disease biomarkers in human serum are often obscured by highly abundant proteins like human serum albumin (HSA) and immunoglobulins (IgGs).
  • Conventional methods for depleting these abundant proteins are slow, cause sample dilution, and typically cannot process multiple samples concurrently.

Purpose of the Study:

  • To develop a rapid, automated, and simultaneous method for depleting HSA and IgGs from human serum.
  • To improve the detection sensitivity of low-abundance biomarkers in proteomic analyses.

Main Methods:

  • Utilized superparamagnetic beads coated with anti-HSA, Protein A, and Protein G.
  • Employed digital microfluidics (DMF) for precise manipulation of the magnetic beads and serum samples.
  • Processed four serum samples simultaneously for efficient protein depletion.

Main Results:

  • Achieved up to 95% depletion efficiency for HSA and IgGs within 10 minutes.
  • Demonstrated an approximately 4-fold increase in the signal-to-noise ratio for detecting the low-abundance protein hemopexin using MALDI-MS.
  • Enabled simultaneous processing of multiple samples, reducing overall analysis time.

Conclusions:

  • The developed DMF-based magnetic bead method offers a fast and efficient approach for abundant protein depletion in serum.
  • This technique significantly enhances the detection of low-abundance biomarkers, holding promise for improved disease diagnosis.
  • The automation and multiplexing capabilities of this method represent a substantial advancement in proteomic sample preparation for biomarker discovery.

Related Concept Videos